Profund Advisors LLC Lowers Stake in Cardinal Health, Inc. $CAH

Profund Advisors LLC cut its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 7.8% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 3,048 shares of the company’s stock after selling 257 shares during the period. Profund Advisors LLC’s holdings in Cardinal Health were worth $512,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of CAH. Greykasell Wealth Strategies Inc. acquired a new stake in Cardinal Health during the 1st quarter worth approximately $26,000. Jones Financial Companies Lllp raised its stake in shares of Cardinal Health by 198.3% in the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after acquiring an additional 14,034 shares during the period. Atlantic Edge Private Wealth Management LLC lifted its holdings in shares of Cardinal Health by 75.0% during the 2nd quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock valued at $29,000 after acquiring an additional 75 shares in the last quarter. NewSquare Capital LLC boosted its position in Cardinal Health by 100.0% during the 2nd quarter. NewSquare Capital LLC now owns 214 shares of the company’s stock worth $36,000 after purchasing an additional 107 shares during the period. Finally, GW&K Investment Management LLC increased its holdings in Cardinal Health by 113.4% in the 1st quarter. GW&K Investment Management LLC now owns 271 shares of the company’s stock valued at $37,000 after purchasing an additional 144 shares in the last quarter. 87.17% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, insider Michelle D. Greene sold 13,500 shares of the stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $2,009,070.00. Following the transaction, the insider owned 14,976 shares of the company’s stock, valued at approximately $2,228,728.32. This trade represents a 47.41% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Jessica L. Mayer sold 38,078 shares of Cardinal Health stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $5,666,767.96. Following the completion of the transaction, the insider owned 48,457 shares of the company’s stock, valued at $7,211,370.74. This trade represents a 44.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 271,676 shares of company stock worth $40,489,525. Company insiders own 0.12% of the company’s stock.

Cardinal Health Stock Down 0.3%

Shares of CAH opened at $204.14 on Thursday. The firm has a market cap of $48.50 billion, a price-to-earnings ratio of 31.65, a PEG ratio of 1.39 and a beta of 0.72. The business’s 50 day moving average is $163.33 and its two-hundred day moving average is $158.16. Cardinal Health, Inc. has a 52-week low of $114.60 and a 52-week high of $207.47.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, topping analysts’ consensus estimates of $2.22 by $0.33. The business had revenue of $64.01 billion during the quarter, compared to the consensus estimate of $59.41 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The business’s quarterly revenue was up 22.4% compared to the same quarter last year. During the same quarter last year, the company earned $1.88 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. On average, equities analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd will be paid a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date is Friday, January 2nd. Cardinal Health’s dividend payout ratio is 30.77%.

Analysts Set New Price Targets

A number of research analysts have commented on the company. Citigroup boosted their price objective on Cardinal Health from $165.00 to $190.00 and gave the stock a “neutral” rating in a research note on Friday, October 31st. Argus boosted their price target on Cardinal Health from $189.00 to $211.00 and gave the stock a “buy” rating in a research report on Tuesday, November 4th. TD Cowen upped their price target on Cardinal Health from $183.00 to $225.00 and gave the stock a “buy” rating in a report on Monday, November 3rd. Wall Street Zen upgraded shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, November 8th. Finally, Mizuho upped their target price on shares of Cardinal Health from $170.00 to $210.00 and gave the company an “outperform” rating in a research note on Monday, November 3rd. Twelve investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $205.00.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.